Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
F-18-NaF PET/CT Findings in Fibrous Dysplasia
F-18-FDG PET/CT in Anti-LGI1 Encephalitis Initial and Follow-Up Findings
F-18-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines
F-18-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with F-18-FDG and bioluminescence imaging
F-18-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
F-18 fluorodeoxyglucose positron emission tomography study of impaired emotion processing in first episode schizophrenia
F-18-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer
F-18-GE-180: a novel TSPO radiotracer compared to C-11-R-PK11195 in a preclinical model of stroke
F-18-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry
F-18-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data
F-18-fluoromethylcholine (FCho), F-18-fluoroethyltyrosine (FET), and F-18-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: A PET study
F-18-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions
F-18-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer
F-18-FDG Uptake at the Surgical Margin after Hepatic Resection: Patterns of Uptake and Differential Diagnosis
F-18 Fluoromisonidazole for Imaging Tumor Hypoxia: Imaging the Microenvironment for Personalized Cancer Therapy
F-18-FDG avid volumes on pre-radiotherapy FDG PET as boost target delineation in non-small cell lung cancer
F-18-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer
F-18-Fluorodeoxyglucose Positron Emission Tomography-Guided Sampling of Mediastinal Lymph Nodes in the Diagnosis of Cardiac Sarcoidosis
F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-alpha antagonist, in rheumatoid arthritis: A prospective pilot study
F-18-FLT PET Imaging in a Patient With Sarcoidosis With Cardiac Involvement
F-18-FDG PET/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor
F-18-FDG and F-18-Florbetapir PET in Clinical Practice Regional Analysis in Mild Cognitive Impairment and Alzheimer Disease
F-18-Fluorothymidine PET-CT for Resected Malignant Gliomas before Radiotherapy: Tumor Extent according to Proliferative Activity Compared with MRI
F-18-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica
F-18-sodium fluoride PET/CT for the in vivo visualization of Monckeberg's sclerosis in a diabetic patient
F-18-FDG PET/CT Role in Staging of Gastric Carcinomas: Comparison with Conventional Contrast Enhancement Computed Tomography
F-18-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders
F-18-FDG PET/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis
F-18-FDG uptake and its clinical relevance in primary gastric lymphoma
F-18 Fluorodeoxyglucose PET in Fournier Gangrene
F-18-FDG PET/CT in a case of intravascular large B-cell lymphoma
F-18-FDG PET and MRS of the early stages of subacute sclerosing panencephalitis in a child with a normal initial MRI
F-18 FDG PET/CT Findings of Dedifferentiated Acinic Cell Carcinoma
F-18 FDG PET/CT Imaging of a Leydig Cell Tumor
F-18-FDG PET for Routine Posttreatment Surveillance in Oral and Oropharyngeal Squamous Cell Carcinoma REPLY
F-18-FDG PET in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: A Study on Inter- and Intraobserver Agreement
F-18-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma
F-18-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis
F-18-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
F-18-Fallypride binding potential in patients with schizophrenia compared to healthy controls
F-18-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to F-18-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
F-18 FDG PET/CT Findings in Pulmonary Necrotizing Sarcoid Granulomatosis
F-18-FDG PET and Myocardial Viability Assessment: Trials and Tribulations
F-18-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with F-18-FDG PET and immunohistochemistry
F-18-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
F-18-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging
F-18-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors Correlation in a PET-CT study
F-18-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of alpha(v)beta(3) Integrin Expression
F-18- and C-11-labelling of quantum dots with n.c.a. [F-18]fluoroethyltosylate and [C-11]methyliodide: a feasibility study
F-18-Fluorodeoxyglucose-PET for Patients With Suspected Spondylitis Showing Modic Change
F-18-FDG PET imaging of progressive massive fibrosis
F-18-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics
F-18-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
F-18-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer